drugset / Trial / NCT00010231

Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00010231 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Combining calcitriol with dexamethasone may increase the effectiveness of therapy by making cancer cells more sensitive to dexamethasone. PURPOSE: Phase I trial to study the effectiveness of calcitriol combined with dexamethasone in treating patients who have prostate cancer that has not responded to previous hormone therapy.

Timeline

Start
1999-06
Primary completion
2002-08
Completion
2002-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Oral

Indications